|
Market Closed -
Nasdaq
21:00:00 12/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 507.00 USD | -0.60% |
|
+0.70% | +11.83% |
| Market Cap | 129B 115B 107B 97.27B 183B 12,284B 185B 1,289B 504B 6,339B 483B 472B 20,399B | P/E 2026 * |
44.8x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 123B 110B 103B 93.07B 176B 11,754B 177B 1,233B 483B 6,066B 462B 452B 19,519B | EV / Sales 2026 * |
9.27x | EV / Sales 2027 * | 8.17x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
CBOE
| VRTX | Real-time | |
|
Tradegate
| VX1 | Real-time | |
|
Mexican S.E.
| VRTX * | End-of-day quote | |
|
Boerse Muenchen
| VX1 | Real-time | |
|
Borsa Italiana
| 1VRTX | End-of-day quote | |
|
London S.E.
| 0QZU | Delayed | |
|
Xetra
| VX1 | Delayed | |
|
Börse Stuttgart
| VX1 | Delayed | |
|
Deutsche Boerse AG
| VX1 | Delayed | |
|
Wiener Boerse
| VRTX | End-of-day quote | |
|
CBOE
| 0QZU | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.60% | ||
| 1 week | +0.70% | ||
| Current month | -3.02% | ||
| 1 month | -1.64% | ||
| 3 months | +4.45% | ||
| 6 months | +16.21% | ||
| Current year | +11.83% |
| 1 week | 498.9 |  | 514.9 |
| 1 month | 496.15 | | 529.89 |
| Current year | 412.27 | | 560.25 |
| 1 year | 403.16 | | 560.25 |
| 3 years | 341.9 | | 560.25 |
| 5 years | 177.71 | | 560.25 |
| 10 years | 71.46 | | 560.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 70 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 17/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/08/26 | Free | Controller/Auditor | 5,000 | 0.0020% | ||
| 27/08/26 | Don | Director | -6,000 | 0.0024% | ||
| 21/07/26 | Free | General Counsel | 8,251 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | +0.70% | +24.33% | +37.77% | 129B | |
| +0.28% | +3.46% | +41.89% | +93.71% | 1,051B | |
| +0.88% | +4.27% | +38.28% | +68.70% | 630B | |
| +1.68% | +5.78% | +21.96% | +89.56% | 489B | |
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | |
| +0.61% | +3.18% | +24.05% | +42.46% | 344B | |
| +0.72% | +2.99% | +14.29% | +34.71% | 272B | |
| +0.23% | +2.23% | -5.91% | +8.15% | 246B | |
| +0.65% | +3.62% | +43.93% | +46.50% | 224B | |
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | |
| Average | +0.33% | +2.87% | +30.03% | +55.79% | 393.3B | |
| Weighted average by Cap. | +0.38% | +3.09% | +33.75% | +65.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.26B 11.87B 11.07B 10.04B 18.93B 1,268B 19.05B 133B 52.07B 654B 49.82B 48.72B 2,105B | 14.56B 13.04B 12.15B 11.02B 20.79B 1,392B 20.92B 146B 57.17B 718B 54.71B 53.49B 2,312B |
| Net income | 2.95B 2.64B 2.46B 2.23B 4.21B 282B 4.23B 29.56B 11.57B 145B 11.07B 10.83B 468B | 4.81B 4.31B 4.01B 3.64B 6.87B 460B 6.91B 48.23B 18.88B 237B 18.06B 17.66B 763B |
| Net Debt | -5.54B -4.96B -4.63B -4.2B -7.92B -530B -7.97B -55.6B -21.77B -274B -20.83B -20.37B -880B | -9.58B -8.58B -8B -7.25B -13.68B -916B -13.77B -96.09B -37.62B -473B -35.99B -35.2B -1,521B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/10/26 | US$507.00 | -0.60% | 952,687 |
| 09/10/26 | US$510.08 | +1.36% | 1,480,861 |
| 08/10/26 | US$503.25 | -0.47% | 1,487,972 |
| 07/10/26 | US$505.64 | +0.66% | 806,840 |
| 06/10/26 | US$502.31 | -0.24% | 775,071 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
